SCHEMBL17469449

SCHEMBL17469449

CNCCN(C)Cc1n[nH]c2ccc(Oc3ccc(C)cc3)cc12

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PRMT1 Q99873 8/20 0.37
▸ CARM1 Q86X55 2/20 0.37
▸ PRMT5 O14744 1/20 0.35
▸ WDR77 Q9BQA1 1/20 0.35
▸ KDM1A O60341 1/20 0.34
▸ TTK P33981 1/20 0.32
▸ HTR2A P28223 1/20 0.32
▸ HSP90AA1 P07900 2/20 0.32
▸ HSP90AB1 P08238 2/20 0.32
▸ GAA P10253 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ SIGMAR1 Q99720 1/20 0.30
▸ ALDH1A1 P00352 2/20 0.30
▸ KDM4E B2RXH2 1/20 0.30
▸ HPGD P15428 1/20 0.30
▸ HSD17B10 Q99714 1/20 0.30
▸ LRRK2 Q5S007 1/20 0.30
▸ LMNA P02545 1/20 0.30
▸ HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16120045 0.91 TTK (0.39) PRMT1CARM1TTKSIGMAR1KDM4E
SCHEMBL17469509 0.91 PRMT1 (0.43) PRMT1PRMT5WDR77HTR2AHSP90AA1
SCHEMBL17469470 0.90 HSP90AA1 (0.37) PRMT1CARM1HSP90AA1HSP90AB1ALDH1A1
SCHEMBL17469497 0.90 PRMT1 (0.38) PRMT1CARM1PRMT5WDR77HTR2A
SCHEMBL17469503 0.88 PRMT1 (0.46) PRMT1CARM1LRRK2
SCHEMBL17469508 0.87 PRMT1 (0.41) PRMT1
SCHEMBL17469502 0.87 LRRK2 (0.40) PRMT5WDR77KDM1ALRRK2
SCHEMBL17469504 0.86 HTR2A (0.44) PRMT1HTR2ACYP2C9ALDH1A1KDM4E
SCHEMBL17469445 0.86 FADS1 (0.40) PRMT1PRMT5WDR77TTKHTR2A
SCHEMBL20066376 0.86 PRMT1 (0.33) PRMT1CARM1SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180105497-A1 ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF Epizyme, Inc. (US) 2018-04-19 — — US disclosed
US-9765035-B2 Arginine methyltransferase inhibitors and uses thereof Epizyme, Inc. (US) 2017-09-19 — — US disclosed
US-20160024017-A1 ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF Epizyme, Inc. (US) 2016-01-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160024017-A1 ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF PRMT1, PRMT3, PRMT5 PRMT1 1/4885CARM1 12/4885PRMT5 3/4885
US-20180105497-A1 ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF PRMT1, PRMT3, PRMT5 PRMT1 1/4885CARM1 12/4885PRMT5 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback